[B! Valproate] iDESã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯

iDES id:iDES

Valproateã«é–¢ã™ã‚‹iDESã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯ (6)

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

${{author_name}}$
{{author_name}}{{created}}
{{ #comment }}{{ comment }}{{ /comment }}
- {{ label }}

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

å¦Šå¨ ä¸ã®ãƒãƒ«ãƒ—ãƒé…¸æœç”¨ã«ã‚ˆã‚‹è‡ªé–‰ç—‡ã®ãƒªã‚¹ã‚¯
å¦Šå¨ ä¸ã®ãƒãƒ«ãƒ—ãƒé…¸æœç”¨ã«ã‚ˆã‚‹è‡ªé–‰ç—‡ã®ãƒªã‚¹ã‚¯ ãƒ‡ãƒ³ãƒžãƒ¼ã‚¯ã§ã®70ä¸‡äººã®åã©ã‚‚ã®ç ”ç©¶ã«ã‚ˆã‚Šã€å¦Šå¨ ä¸ã®æŠ—ã¦ã‚“ã‹ã‚“è–¬ãƒãƒ«ãƒ—ãƒé…¸æœç”¨ã«ã‚ˆã‚Šã€è‡ªé–‰ç—‡ã‚¹ãƒšã‚¯ãƒˆãƒ©ãƒ éšœå®³ASDã®ç™ºç—‡ãƒªã‚¹ã‚¯ã¯3å€ä»¥ä¸Šã¨ãªã‚‹å¯èƒ½æ€§ãŒã‚ã‚‹ã¨ã„ã†ã€‚ ã“ã‚Œã¾ã§ã®ç ”ç©¶ã§ã€å…ˆå¤©æ€§éšœå®³ã‚„çŸ¥èƒ½éšœå®³ã®ç™ºç—‡ãŒãžã†ã‹ã™ã‚‹ã“ã¨ã¯ã‚ã‹ã£ã¦ã„ãŸãŒã€æ–°ãŸã«è‡ªé–‰ç—‡ã¨ã®é–¢é€£ã«ã¤ã„ã¦ã“ã‚Œã¾ã§ã§æœ€å¼·ã®è¨¼æ‹ ãŒå‡ºãŸã“ã¨ã«ãªã‚‹ã€‚ 1996-2006å¹´ã«ãƒ‡ãƒ³ãƒžãƒ¼ã‚¯ã§ç”Ÿã¾ã‚ŒãŸåã©ã‚‚656,000äººã‚’è¿½è·¡ã—ã€æ¯è¦ªã®ç´„6,600äººãŒã¦ã‚“ã‹ã‚“ã‚’æŒã¡ã€508äººã¯å¦Šå¨ ä¸ã«ãƒãƒ«ãƒ—ãƒé…¸ã‚’æœç”¨ã—ã¦ã„ãŸã€‚2010å¹´ã¾ã§ã«ã€ãã®4.4%ãŒASDã¨è¨ºæ–ã•ã‚Œã€2.5%ã¯è‡ªé–‰ç—‡ã ã£ãŸã€‚ ----------------------------------------------------- Epilepsy drug in pregnancy tied to autism risk http:/
iDES 2013/05/16
Valproate
ãƒªãƒ³ã‚¯
Divalproex in Posttraumatic Stress Disorder: An Open-Label Clinical Trial - Journal of Traumatic Stress
iDES 2011/11/25
PTSD

Valproate
ãƒªãƒ³ã‚¯
ç–«å¦æ‰¹è©•:æŠ—ã¦ã‚“ã‹ã‚“è–¬ã®ä¸€éƒ¨ã§ã€è‡ªæ®ºè¡Œå‹•ã®ãƒªã‚¹ã‚¯ä¸Šæ˜‡ã€‚
2010å¹´05æœˆ25æ—¥ æŠ—ã¦ã‚“ã‹ã‚“è–¬ã®ä¸€éƒ¨ã§ã€è‡ªæ®ºè¡Œå‹•ã®ãƒªã‚¹ã‚¯ä¸Šæ˜‡ã€‚ ç±³å›½ã®15æ³ä»¥ä¸Šã®æ‚£è€…ã«å¯¾ã™ã‚‹æŠ—ã¦ã‚“ã‹ã‚“è–¬ã®æ–°è¦å‡¦æ–¹297,620ä»¶ã‚’ï¼–ãƒ¶æœˆè¿½è·¡ã—ãŸã¨ã“ã‚ã€13ç¨®é¡žã®æŠ—ã¦ã‚“ã‹ã‚“è–¬ã®ã†ã¡ï¼•ç¨®é¡žã§è‡ªæ®ºè¡Œå‹•ï¼ˆæœªé‚ã¨æ—¢é‚ï¼‰ã®ãƒªã‚¹ã‚¯ãŒé«˜ã‹ã£ãŸã€‚è«–æ–‡ã¯Journal of the American Medical Association 2010å¹´ï¼”æœˆ14æ—¥å·ã«æŽ²è¼‰ã•ã‚ŒãŸã€‚ æŠ—ã¦ã‚“ã‹ã‚“è–¬ã¯ã€ã¦ã‚“ã‹ã‚“ä»¥å¤–ã®ç–¾æ‚£ï¼ˆèºã†ã¤ç—…ã€èºç—…ã€ç¥žçµŒç—›ã€ç¥žçµŒå› æ€§ç–¼ç—›ï¼‰ã«ã‚‚é©å¿œã¨ã—ã¦ä½¿ç”¨ã•ã‚Œã¦ãŠã‚Šã€ãã®ä»–ã®ç–¾æ‚£ï¼ˆã†ã¤ç—…æ€§ç”Ÿæ¶¯ã€ã‚¢ãƒ«ã‚³ãƒ¼ãƒ«ã‚„è–¬ç‰©ä¾å˜ãªã©ï¼‰ã¸ã®é©å¿œå¤–ä½¿ç”¨ã‚‚å¢—ãˆã¦ã„ã‚‹ï¼ˆé©å¿œã¨ãªã‚‹ç–¾æ‚£ã¯ç±³å›½ã¨æ—¥æœ¬ã§ç•°ãªã‚‹å ´åˆãŒã‚ã‚‹ï¼‰ã€‚ 2008å¹´ç±³å›½é£Ÿå“åŒ»è–¬å“å±€ã¯ã€æŠ—ã¦ã‚“ã‹ã‚“è–¬ã¨ãƒ—ãƒ©ã‚»ãƒœã‚’æ¯”ã¹ãŸè‡¨åºŠè©¦é¨“199ä»¶ã®ãƒ‡ãƒ¼ã‚¿ã‚’é›†è¨ˆã—ã¦11ç¨®é¡žã®æŠ—ã¦ã‚“ã‹ã‚“è–¬ã®ç·åˆè©•ä¾¡ã‚’è¡Œãªã„ã€æŠ—ã¦ã‚“ã‹ã‚“è–¬å…¨ä½“ã¨ã—ã¦è‡ªæ®ºå¿µæ…®ã‚„è‡ªæ®ºè¡Œå‹•ã®ãƒªã‚¹ã‚¯ãŒ1
iDES 2010/05/25
ãƒˆãƒ”ãƒ©ãƒžãƒ¼ãƒˆç¾¤åŸºæº–ç¾¤ã¨ã—ã¦è‡ªæ®ºè¡Œå‹•ã®ãƒªã‚¹ã‚¯ã¯ã‚¬ãƒãƒšãƒ³ãƒãƒ³ã§1.42å€ã€ãƒ©ãƒ¢ãƒˆãƒªã‚®ãƒ³ã§1.84å€ã€ã‚ªã‚ã‚·ã‚«ãƒ«ãƒã‚¼ãƒ”ãƒ³ã§2.07å€ã€ãƒã‚¢ã‚¬ãƒ“ãƒ³ã§2.41å€ã€ãƒãƒ«ãƒ—ãƒé…¸ã§1.65å€ã€‚

Topiramate

Gabapentin

Valproate

Tiagabine
ãƒªãƒ³ã‚¯
ãƒ‡ãƒ‘ã‚±ãƒ³ï½œç²¾ç¥žç§‘åŒ»ãƒ–ãƒã‚°ã€é•·å´Žåºƒå³¶åŽŸçˆ†ãƒ»ç¦å³¶åŽŸç™ºãƒ»ã‚³ãƒãƒŠãƒ»ç¬¬äºŒæ¬¡å¤§æˆ¦ãƒ»åŒ—æœé®®ãƒã‚·ã‚¢æ ¸ãƒ»å…ç«¥è™å¾…ãƒ»DVãƒ»ãƒ¬ã‚¤ãƒ—è¤‡é›‘æ€§PTSDã®è–¬ç‰©ç™‚æ³•
é•·å´Žåºƒå³¶åŽŸçˆ†ãƒ»é˜ªç¥žå¤§éœ‡ç½ãƒ»ç¦å³¶åŽŸç™ºäº‹æ•…ãƒ»æ±æ—¥æœ¬å¤§éœ‡ç½ãƒ»åŒ—æœé®®æ ¸ã®è„…å¨ãƒ»ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ãƒ‘ãƒ³ãƒ‡ãƒŸãƒƒã‚¯ã§ã‚‚ãªãŠPTSDå¦èªã‚’ã‚„ã‚ã‚ˆã†ã¨ã—ãªã„æ—¥æœ¬äººã¯åœ°éœ‡åˆ—å³¶ã§ã®åŽŸç™ºå†ç¨¼åƒã§æ»…äº¡ã—ã‚ˆã†ã¨ã—ã¦ã„ã¾ã™ã€PTSDã‚’èªã‚ã‚‹ã¨ã¯ãã‚Œã‚’ç”Ÿã¿å‡ºã™å±é™ºã‚’å›žé¿ã™ã‚‹ã“ã¨ã«ã¤ãªãŒã‚‹
iDES 2010/05/23
Valproate
ãƒªãƒ³ã‚¯
èª¿å‰¤è–¬å±€æ—¥è¨˜ï¼å¾æ”¾æ€§è£½å‰¤
iDES 2010/04/08
ãƒ‡ãƒ‘ã‚±ãƒ³ï¼²ã€€ã‚’ã€€å™›ã‚“ã§æœç”¨ã—ã¦ã‚‚è‰¯ã„ï¼Ÿ "ãã®ã¾ã¾ä¾¿ã«å‡ºã¦ãã¦ã—ã¾ã£ã¦ã„ã‚‹ã¿ãŸã„ãªã‚“ã§ã™ï½¡"

Valproate
ãƒªãƒ³ã‚¯
L-ã‚«ãƒ«ãƒ‹ãƒãƒ³ã«ã¤ã„ã¦
L-ã‚«ãƒ«ãƒ‹ãƒãƒ³ã€ã‚³ã‚¨ãƒ³ã‚¶ã‚¤ãƒ Q10ãŠã‚ˆã³Î±-ãƒªãƒé…¸ã¯ã€ãƒ€ã‚¤ã‚¨ãƒƒãƒˆåŠ¹æžœã‚’æ¨™æ¦œã™ã‚‹ã€Œã„ã‚ã‚†ã‚‹å¥åº·é£Ÿå“ã€ã«å«ã¾ã‚Œã¦ã„ã‚‹è©±é¡Œã®é£Ÿå“ç´ æã§ã™ã€‚ç”ŸåŒ–å¦ã®æ•™ç§‘æ›¸ã§ã¯ã€ã“ã‚Œã‚‰ã®ç´ æã¯ã„ãšã‚Œã‚‚ã‚¨ãƒãƒ«ã‚®ãƒ¼æ¶ˆè²»ã‚„ã‚¨ãƒãƒ«ã‚®ãƒ¼ç”£ç”Ÿã«é‡è¦ãªå½¹å‰²ã‚’æžœãŸã™ã“ã¨ãŒç¤ºã•ã‚Œã¦ã„ã¾ã™(1)ã€‚å¾“ã£ã¦ã€ã“ã‚Œã‚‰é£Ÿå“ç´ æã®æ‘‚å–ã¯è„‚è‚ªç‡ƒç„¼ã‚’ä¿ƒã—ã€ãƒ€ã‚¤ã‚¨ãƒƒãƒˆã«åŠ¹æžœçš„ã«ä½œç”¨ã™ã‚‹å¯èƒ½æ€§ãŒå¼·èª¿ã•ã‚Œè²©å£²ã•ã‚Œã¦ã„ã¾ã™ã€‚ãã“ã§æœ¬ãƒŸãƒ‹ãƒ¬ãƒ“ãƒ¥ãƒ¼ã§ã¯ã€è„‚è‚ªç‡ƒç„¼ã«å¯†æŽ¥ã«é–¢ä¸Žã™ã‚‹é£Ÿå“ç´ æã®ä¸€ã¤ã§ã‚ã‚‹L-ã‚«ãƒ«ãƒ‹ãƒãƒ³ã‚’å–ã‚Šä¸Šã’ã€ãã®ä½œç”¨ãƒ¡ã‚«ãƒ‹ã‚ºãƒ ã‚„äººã§ã®ç ”ç©¶æˆæžœã«ã¤ã„ã¦ç´¹ä»‹ã—ã€æœ€è¿‘è©±é¡Œã®æ©Ÿèƒ½æ€§ã‚’è€ƒãˆã¦ã¿ãŸã„ã¨æ€ã„ã¾ã™ã€‚ ï¼‘. L-ã‚«ãƒ«ãƒ‹ãƒãƒ³ã¨ã¯ L-ã‚«ãƒ«ãƒ‹ãƒãƒ³ï¼ˆå›³ï¼1ï¼‰ã¯ãƒªã‚¸ãƒ³ã¨ãƒ¡ãƒã‚ªãƒ‹ãƒ³ã¨è¨€ã†ï¼’ã¤ã®ã‚¢ãƒŸãƒŽé…¸ã‹ã‚‰è‚è‡“ã‚„è…Žè‡“ã§ä½œã‚‰ã‚Œã‚‹ç”Ÿä½“å¾®é‡æˆåˆ†ã§ã™ã€‚ã“ã®ä»–ã«ã‚‚è‚‰ãªã©ã‹ã‚‰æ‘‚å–ã•ã‚Œã¾ã™ã€‚L-ã‚«ãƒ«ãƒ‹ãƒãƒ³ã¯ã€ä½“å†…ã§ã‚‚é€ ã‚‰ã‚Œã‚‹æˆåˆ†ã§ã™ãŒã€å¹´é½¢ã¨ã¨ã‚‚ã«ãã®ç”Ÿæˆé‡ã¯ä½Žä¸‹ã™ã‚‹ã“ã¨
iDES 2010/04/08
"ãƒãƒ«ãƒ—ãƒé…¸ã®æœç”¨ã¯ã€ã‚«ãƒ«ãƒ‹ãƒãƒ³æ¬ ä¹ã‚’å¼•ãèµ·ã“ã™"

L-ã‚«ãƒ«ãƒ‹ãƒãƒ³

Valproate
ãƒªãƒ³ã‚¯
1